Chargement en cours...
Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome
OBJECTIVE: Neonatal abstinence syndrome (NAS)—a clinical entity of infants from in utero exposure to psychoactive xenobiotic and buprenorphine—has been successfully used to treat NAS. However, nothing is known about the pharmacokinetics (PK) of buprenorphine in neonates with NAS. To our knowledge, t...
Enregistré dans:
| Publié dans: | Pharmacotherapy |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5119858/ https://ncbi.nlm.nih.gov/pubmed/26172282 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1610 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|